Literature DB >> 19425534

Antitumor agents. 266. Design, synthesis, and biological evaluation of novel 2-(furan-2-yl)naphthalen-1-ol derivatives as potent and selective antibreast cancer agents.

Yizhou Dong1, Qian Shi, Yi-Nan Liu, Xiang Wang, Kenneth F Bastow, Kuo-Hsiung Lee.   

Abstract

In a continuing study, we explored how the individual rings in neo-tanshinlactone (1) influence its potent and selective in vitro antibreast cancer activity. Accordingly, we discovered a novel class of antibreast cancer agents, 2-(furan-2-yl)naphthalen-1-ol derivatives, based on an active C-ring opened model compound 5. Further optimization led to 18 and 21, which showed decreased cytotoxic potency but better selectivity than neo-tanshinlactone analogue 2. Interestingly, 20 showed broad cytotoxicity against human cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19425534      PMCID: PMC2754228          DOI: 10.1021/jm9001567

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Synthesis of GTP-derived Ras ligands.

Authors:  Laurent Soulère; Courtney Aldrich; Oliver Daumke; Robert Gail; Lars Kissau; Alfred Wittinghofer; Herbert Waldmann
Journal:  Chembiochem       Date:  2004-10-04       Impact factor: 3.164

2.  Antitumor agents. 254. Synthesis and biological evaluation of novel neo-tanshinlactone analogues as potent anti-breast cancer agents.

Authors:  Xihong Wang; Kyoko Nakagawa-Goto; Kenneth F Bastow; Ming-Jaw Don; Yun-Lian Lin; Tian-Shung Wu; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

3.  Ligand-based prediction of active conformation by 3D-QSAR flexibility descriptors and their application in 3+3D-QSAR models.

Authors:  Tamás A Martinek; Ferenc Otvös; Máté Dervarics; Géza Tóth; Ferenc Fülöp
Journal:  J Med Chem       Date:  2005-05-05       Impact factor: 7.446

Review 4.  Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.

Authors:  H Kurokawa; C L Arteaga
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

Review 5.  Estrogen receptors and their downstream targets in cancer.

Authors:  Kazuhiro Ikeda; Satoshi Inoue
Journal:  Arch Histol Cytol       Date:  2004-12

6.  Antitumor Agents. 239. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza.

Authors:  Xihong Wang; Kenneth F Bastow; Chang-Ming Sun; Yun-Lian Lin; Hsi-Jung Yu; Ming-Jaw Don; Tian-Shung Wu; Seikou Nakamura; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2004-11-04       Impact factor: 7.446

Review 7.  EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.

Authors:  F Labrie; C Labrie; A Bélanger; J Simard; S Gauthier; V Luu-The; Y Mérand; V Giguere; B Candas; S Luo; C Martel; S M Singh; M Fournier; A Coquet; V Richard; R Charbonneau; G Charpenet; A Tremblay; G Tremblay; L Cusan; R Veilleux
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

8.  Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.

Authors:  Tove Kirkegaard; Liane M McGlynn; Fiona M Campbell; Sven Müller; Sian M Tovey; Barbara Dunne; Kirsten V Nielsen; Timothy G Cooke; John M S Bartlett
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

9.  Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.

Authors:  Marie Mc Ilroy; Fergal J Fleming; Yvonne Buggy; Arnold D K Hill; Leonie S Young
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

Review 10.  Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.

Authors:  Helen M Coley
Journal:  Cancer Treat Rev       Date:  2008-03-25       Impact factor: 12.111

View more
  12 in total

1.  Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity.

Authors:  Yizhou Dong; Kyoko Nakagawa-Goto; Chin-Yu Lai; Susan L Morris-Natschke; Kenneth F Bastow; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2011-03-21       Impact factor: 2.823

Review 2.  Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.

Authors:  Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

3.  Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues.

Authors:  Yizhou Dong; Qian Shi; Huei-Chen Pai; Chieh-Yu Peng; Shiow-Lin Pan; Che-Ming Teng; Kyoko Nakagawa-Goto; Donglei Yu; Yi-Nan Liu; Pei-Chi Wu; Kenneth F Bastow; Susan L Morris-Natschke; Arnold Brossi; Jing-Yu Lang; Jennifer L Hsu; Mien-Chie Hung; Eva Y-H P Lee; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

4.  Antitumor agents 278. 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs as potent in vitro anti-cancer agents.

Authors:  Yizhou Dong; Kyoko Nakagawa-Goto; Chin-Yu Lai; Susan L Morris-Natschke; Kenneth F Bastow; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2010-05-24       Impact factor: 2.823

5.  Antitumor agents 279. Structure-activity relationship and in vivo studies of novel 2-(furan-2-yl)naphthalen-1-ol (FNO) analogs as potent and selective anti-breast cancer agents.

Authors:  Yizhou Dong; Kyoko Nakagawa-Goto; Chin-Yu Lai; Yoon Kim; Susan L Morris-Natschke; Eva Y-H P Lee; Kenneth F Bastow; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2010-11-21       Impact factor: 2.823

6.  Antitumor agents 281. Design, synthesis, and biological activity of substituted 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogs (ATBO) as potent in vitro anticancer agents.

Authors:  Yizhou Dong; Kyoko Nakagawa-Goto; Chin-Yu Lai; Susan L Morris-Natschke; Kenneth F Bastow; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2010-11-17       Impact factor: 2.823

7.  Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents.

Authors:  Yizhou Dong; Qian Shi; Kyoko Nakagawa-Goto; Pei-Chi Wu; Susan L Morris-Natschke; Arnold Brossi; Kenneth F Bastow; Jing-Yu Lang; Mien-Chie Hung; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem       Date:  2009-12-02       Impact factor: 3.641

Review 8.  Recent Progress of Research on Herbal Products Used in Traditional Chinese Medicine: the Herbs belonging to The Divine Husbandman's Herbal Foundation Canon ( Shén Nóng Běn Cǎo Jīng).

Authors:  Kuo-Hsiung Lee; Susan Morris-Natschke; Keduo Qian; Yizhou Dong; Xiaoming Yang; Ting Zhou; Eileen Belding; Shou-Fang Wu; Koji Wada; Toshiyuki Akiyama
Journal:  J Tradit Complement Med       Date:  2012-01

9.  Design, Synthesis and Antifungal Activity of Coumarin Ring-Opening Derivatives.

Authors:  Ming-Zhi Zhang; Yu Zhang; Jia-Qun Wang; Wei-Hua Zhang
Journal:  Molecules       Date:  2016-10-17       Impact factor: 4.411

10.  Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling.

Authors:  Ana S C Valdeira; Daniel A Ritt; Deborah K Morrison; James B McMahon; Kirk R Gustafson; Jorge A R Salvador
Journal:  Front Chem       Date:  2018-09-28       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.